CommercialCoverageMedium impact
Gastric Electrical Stimulation 7.01.64
Excellus BlueCross BlueShield·Gastroenterology, General Surgery·Digestive System (Gastroenterology)
Effective date
Jan 22, 2026
We identified it
Jun 20, 2026
Summary
Excellus BlueCross BlueShield policy 7.01.64 declares gastric electrical stimulation (GES)/gastric pacing investigational for all indications including gastroparesis and obesity, effective January 22, 2026. This means claims for GES procedures will likely be denied as experimental/investigational services.
Action Required
By January 22, 2026: Billing team must review all pending and future gastric electrical stimulation claims for Excellus BlueCross BlueShield members. Flag these procedures as investigational and expect denials. Providers should inform patients about coverage limitations and obtain advance beneficiary notices when applicable. Reference corporate policy 11.01.03 for experimental services procedures.